Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Dr Reddy’s launches Palonosetron Hydrochloride Injection in US

Dr Reddy’s Laboratories Limited has launched Palonosetron Hydrochloride Injection, 0.25 mg/ml in US.

It has been approved by the US Food and Drug Administration (USFDA) and is a therapeutic equivalent of Aloxi injection. It is used to treat chemotherapy-induced nausea and vomiting sensation.

Further, the injection is available in a single dose vial, packed in a cartoon containing one vial.

Read EquityPandit’s Technical Analysis of Dr Reddy

Get Daily Prediction & Stocks Tips On Your Mobile